Mini review article. Human herpesvirus-6 and the etiology of multiple sclerosis: a literature review

Open access


Background: There is no consensus in the literature on the role of human herpes virus-6 (HHV-6) in multiple sclerosis (MS) onset or progression.

Objective: We evaluated a possible role for HHV-6 in MS onset and progression.

Methods: We conducted a literature search of PubMed and Google scholar with the following search terms: (“multiple sclerosis” OR “MS”) and (“Human Herpes Virus-6” OR “HHV-6”).

Results: A total 21 publications were retrieved, of which 19 case-control studies were included. A further 25 articles were retrieved for background information.

Conclusion: There was insufficient evidence to support a role of HHV-6 in MS onset and progression.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Enbom M Wang F-Z Fredrikson S Martin C Dahl H Linde A. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol. 1999; 6:545-9

  • 2. Mancuso R Delbue S Borghi E Pagani E Calvo MG Caputo D et al. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol. 2007; 79:192-9

  • 3. Challoner PB Smith KT Parker JD Macleod DL Coulter SN Rose TN et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA. 1995; 92:7440-4.

  • 4. Enbom M. Human herpesvirus 6 in the pathogenesis of multiple sclerosis. APMIS. 2001; 109:401-11.

  • 5. Stinissen P Raus J Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol. 1997; 17:33-75.

  • 6. Hunter SF Hafler DA. Ubiquitous pathogens. Links between infection and autoimmunity in MS? Neurology. 2000; 55:164-5.

  • 7. Brown KA. Factors modifying the migration of lymphocytes across the blood-brain barrier. Int Immunopharmacol. 2001; 1:2043-62.

  • 8. Bruck W. Clinical implications of neuropathological findings in multiple sclerosis. J Neurol. 2005; 252:III/ 10-4.

  • 9. Harbige LS Sharief MK. Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis. Br J Nutr. 2007; 98:S46-53.

  • 10. Gompels UA Nicholas J Lawrence G Jones M Thomson BJ Martin MED et al. The DNA sequence of human herpes virus-6 structure coding content and genome evolution. Virology. 1995; 209:29-51.

  • 11. Sanders VJ Felisan S Waddell A Tourtellotte WW. Detection of herpesviridae in post-mortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol. 1996; 2:249-58.

  • 12. Taus C Pucci E Cartechini E Fie A Guiliani G Clementi M et al. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol Scand. 2000; 101:224-8.

  • 13. Opsahl ML Kennedy PGE. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain. 2005; 128:516-27.

  • 14. Matute C Alberdi E Domercq M Perez-Cerda F Perez-Samart☐n A Sanchez-Gomez MV. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 2001; 24: 224-30.

  • 15. Miller G. The dark side of glia. Science. 2005; 308: 778-81.

  • 16. Farooqui AA Horrocks LA Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem. 2007; 101:577-99.

  • 17. Clark DA. Human herpesvirus 6 and multiple sclerosis. Herpes. 1999; 6:73-7.

  • 18. Gopfert E Pytlik S Debuch H. 2′3′-Cyclic nucleotide 3′-phosphohydrolase and lipids of myelin from multiple sclerosis and normal brains. J Neurochem. 1980; 34: 732-9.

  • 19. Martin C Enbom M Soderstrom M Fredrikson S Dahl H Lycke J et al. Absence of seven human herpesviruses Including HHV-6 by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand. 1997; 95:280-3.

  • 20. Franciotta D Bestetti A Sala S Perucca P Jarius S Price RW et al. Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum. Acta Neurol Belg. 2009; 109:277-82.

  • 21. Alvarez-Lafuente R Garcia-Montojo M De Las Heras V Dominguez-Mozo MI Bartolome M Benito- Martin MS et al. Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult Scler. 2008; 14:595-601.

  • 22. Mancuso R Hernis A Cavarretta R Caputo D Calabrese E Nemni R et al. Detection of viral DNA sequences in the cerebrospinal fluid of patients with Multiple Sclerosis. J Med Virol. 2009; 82:1051-7.

  • 23. Sotelo J Ordonez G Pineda B Flores J. The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg. 2014; 119: 44-8.

  • 24. van Nierop GP Hintzen RQ Verjans GMGM. Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands. J. Neurovirol. 2014; DOI 10.1007/s13365-014-0248-4.

  • 25. Mechelli R Vittori D Coarelli G Aimati L De Luca O Romano S et al. Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. MSJ. 2014; 20:638.

  • 26. Ahram M El-Omar A Baho Y Lubad MA. Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients. Acta Neurol Scand. 2009; 120:430-5.

  • 27. Lublin FD Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology. 1996; 46:907-11.

  • 28. Reipert B. Multiple sclerosis: a short review of the disease and its differences between men and women. J Men’s Health Gen. 2004; 1:334-40.

  • 29. Secchiero P Zella D Crowley RW Gallo RC Lusso P. Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol. 1995; 33:2124-30.

  • 30. Chapenko S Millers A Nora Z Logina I Kukaine R Murovska M. Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol. 2003; 69:111-7.

  • 31. Alvarez-Lafuente R Martin-Estefania C de Las Heras V Castrillo C Picazo JJ Varela de Seijas E et al. Active human herpesvirus 6 infection in patients with multiple sclerosis. Arch Neurol. 2002; 59:929-33.

  • 32. Behzad-Behbahani A Hadi Mikaeili M Entezam M Mojiri A Pour GY Arasteh MM et al. Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis. J Microbiol Immunol Infect. 2011; 44:247-51.

  • 33. Ohyashiki JH Takaku T Ojima T Abe K Yamamoto K Zhang Y et al. Transcriptional profiling of human herpesvirus type B (HHV-6B) in an adult T cell leukemia cell line as an in vitro model for persistent infection. Biochem Biophys Res Commun. 2005; 329:11-7.

  • 34. Adams CWM. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull. 1977; 33:15-20.

  • 35. Hay KA Tenser RB. Leukotropic herpesviruses in multiple sclerosis. Mult Scler. 2000; 6:66-8.

  • 36. Sotelo J Ordonez G Pineda B. Varicella-zoster virus at relapses of multiple sclerosis. J Neurol. 2007; 254: 493-500.

  • 37. Hon GM Erasmus RT Matsha T. Low prevalence of human herpesvirus-6 and varicella zoster virus in blood of multiple sclerosis patients irrespective of inflammatory status or disease progression. J Clin Neurosci. 2014; doi:

    • Crossref
    • Zitation exportieren
  • 38. Fredj NB Rotola A Nefzi F Chebel S Rizzo R Caselli E et al. Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors. J Neurovirol. 2006; 18:12-9.

  • 39. Mameli G Astone V Arru G Marconi S Lovato L Serra C et al. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus but not human herpesvirus 6. J Gen Virol. 2007; 88:264-74.

  • 40. Alvarez-Lafuente R Martin-Estefania C de las Heras V Castrillo C Cour I Picazo JJ et al. Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol Scand. 2002; 105:95-9.

  • 41. Ablashi DV Eastman HB Owen CB Roman MM Friedman J Zabriskie JB et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000; 16: 179-91.

  • 42. Ben-Fredj N Ben-Selma W Rotola A Nefzi F Benedetti S Frih-Ayed M et al. Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients. J Neurovirol. 2013; 19:42-7.

  • 43. Alvarez-Lafuente R de las Heras V Bartolome M Picazo JJ Arroyo R. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol. 2004; 61:1523-7.

  • 44. Schippling S Heesen C Zander A Martin R. Stem cell transplantation in multiple sclerosis. J Neurol. 2008; 255:43-7.

  • 45. Compston A Coles A. Multiple sclerosis. Lancet. 2002; 359:1221-31.

  • 46. Chatzimanolis N Kraus J Bauer R Engelhardt B Bregenzer T Kuehne BS et al. CD45RA + ICAM-3 + lymphocytes in interferon-β1b-treated and -untreated patients with relapsing-remitting multiple sclerosis. Acta Neurol Scand. 2004; 110:377-85.

  • 47. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology. 1983; 33:1444-52.

  • 48. Gustafsson R Reitsma R Stralfors A Lindholm A Press R Fogdell-Hahn A. Incidence of human herpesvirus 6 in clinical samples from Swedish patients with demyelinating diseases. J Microbiol Immunol Infect. 2013; doi:

    • Crossref
    • Zitation exportieren
Impact Factor
5-year IMPACT FACTOR: 0.293

CiteScore 2018: 0.30

SCImago Journal Rank (SJR) 2018: 0.172
Source Normalized Impact per Paper (SNIP) 2018: 0.237

Gesamte Zeit Letztes Jahr Letzte 30 Tage
Abstract Views 0 0 0
Full Text Views 197 60 2
PDF Downloads 73 34 0